Lindsay Tara Fourman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Growth Hormone-Releasing Hormone | 6 | 2021 | 213 | 2.300 |
Why?
|
HIV Infections | 20 | 2023 | 16715 | 1.600 |
Why?
|
Lipodystrophy | 1 | 2022 | 147 | 0.770 |
Why?
|
Hypertriglyceridemia | 1 | 2022 | 293 | 0.670 |
Why?
|
Growth Substances | 1 | 2021 | 784 | 0.660 |
Why?
|
Adiposity | 2 | 2019 | 1806 | 0.640 |
Why?
|
Insulin-Like Growth Factor I | 4 | 2021 | 2016 | 0.600 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 294 | 0.570 |
Why?
|
Intra-Abdominal Fat | 2 | 2019 | 591 | 0.570 |
Why?
|
Aspartate Aminotransferases | 1 | 2017 | 418 | 0.550 |
Why?
|
Blood Proteins | 1 | 2021 | 1124 | 0.550 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2022 | 2026 | 0.520 |
Why?
|
Hyperglycemia | 1 | 2024 | 1373 | 0.510 |
Why?
|
Macrophage Activation | 1 | 2018 | 560 | 0.510 |
Why?
|
Alanine Transaminase | 1 | 2017 | 592 | 0.510 |
Why?
|
Interleukin-10 | 1 | 2020 | 1200 | 0.480 |
Why?
|
Anti-Obesity Agents | 1 | 2017 | 217 | 0.480 |
Why?
|
Hypothalamic Diseases | 1 | 2015 | 135 | 0.460 |
Why?
|
Liver | 5 | 2023 | 7475 | 0.460 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2013 | 30 | 0.460 |
Why?
|
Neurosecretory Systems | 1 | 2015 | 231 | 0.450 |
Why?
|
Placenta | 2 | 2022 | 1699 | 0.450 |
Why?
|
Receptor, Melatonin, MT2 | 1 | 2013 | 77 | 0.440 |
Why?
|
Indenes | 1 | 2013 | 57 | 0.440 |
Why?
|
Absorptiometry, Photon | 1 | 2019 | 1725 | 0.440 |
Why?
|
Hepatitis, Autoimmune | 1 | 2013 | 141 | 0.400 |
Why?
|
Fatty Liver | 1 | 2017 | 727 | 0.400 |
Why?
|
Proteomics | 2 | 2023 | 3638 | 0.400 |
Why?
|
Placebos | 3 | 2021 | 1676 | 0.390 |
Why?
|
Amenorrhea | 1 | 2015 | 485 | 0.390 |
Why?
|
Monocytes | 3 | 2022 | 2596 | 0.380 |
Why?
|
Insulin | 1 | 2024 | 6582 | 0.340 |
Why?
|
Heart | 3 | 2022 | 4464 | 0.330 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 3047 | 0.330 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2865 | 0.320 |
Why?
|
Obesity | 3 | 2022 | 12746 | 0.320 |
Why?
|
Insulin Resistance | 1 | 2022 | 3864 | 0.320 |
Why?
|
Antigens, CD | 1 | 2018 | 4026 | 0.300 |
Why?
|
Liver Cirrhosis | 3 | 2023 | 1862 | 0.300 |
Why?
|
Gene Expression | 1 | 2020 | 7798 | 0.300 |
Why?
|
HIV | 3 | 2023 | 1604 | 0.270 |
Why?
|
Infertility | 2 | 2023 | 655 | 0.240 |
Why?
|
Hyperthyroidism | 2 | 2023 | 295 | 0.230 |
Why?
|
HIV-1 | 2 | 2020 | 6939 | 0.220 |
Why?
|
Coronary Artery Disease | 2 | 2020 | 6486 | 0.220 |
Why?
|
Pituitary Diseases | 1 | 2023 | 141 | 0.210 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15160 | 0.210 |
Why?
|
Growth Hormone | 2 | 2020 | 705 | 0.190 |
Why?
|
Female | 25 | 2024 | 380193 | 0.190 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2023 | 472 | 0.190 |
Why?
|
Middle Aged | 17 | 2024 | 213390 | 0.190 |
Why?
|
Dwarfism, Pituitary | 1 | 2020 | 46 | 0.180 |
Why?
|
Infertility, Male | 1 | 2023 | 409 | 0.180 |
Why?
|
Immunity | 2 | 2023 | 1014 | 0.180 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2021 | 216 | 0.180 |
Why?
|
Humans | 31 | 2024 | 744366 | 0.170 |
Why?
|
Thyrotropin | 2 | 2023 | 849 | 0.160 |
Why?
|
Asymptomatic Diseases | 2 | 2018 | 551 | 0.160 |
Why?
|
Hepatitis | 1 | 2020 | 227 | 0.160 |
Why?
|
Oxidative Phosphorylation | 1 | 2020 | 481 | 0.160 |
Why?
|
Blood Glucose | 2 | 2024 | 6254 | 0.160 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2021 | 644 | 0.150 |
Why?
|
Thyroid Function Tests | 1 | 2018 | 286 | 0.150 |
Why?
|
Pregnancy | 4 | 2023 | 29144 | 0.140 |
Why?
|
Longitudinal Studies | 2 | 2023 | 13991 | 0.140 |
Why?
|
Young Adult | 7 | 2021 | 56429 | 0.140 |
Why?
|
Adult | 14 | 2021 | 214052 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20130 | 0.130 |
Why?
|
Hormones | 1 | 2019 | 889 | 0.130 |
Why?
|
Human Growth Hormone | 1 | 2020 | 683 | 0.130 |
Why?
|
Birth Weight | 1 | 2023 | 2069 | 0.130 |
Why?
|
Male | 16 | 2023 | 350115 | 0.130 |
Why?
|
Waist Circumference | 1 | 2019 | 917 | 0.130 |
Why?
|
Double-Blind Method | 4 | 2021 | 12025 | 0.130 |
Why?
|
Sex Factors | 2 | 2019 | 10400 | 0.120 |
Why?
|
Leptin | 1 | 2022 | 1600 | 0.120 |
Why?
|
Hyperprolactinemia | 1 | 2015 | 129 | 0.120 |
Why?
|
Body Mass Index | 2 | 2023 | 12721 | 0.110 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2017 | 841 | 0.110 |
Why?
|
Up-Regulation | 1 | 2023 | 4222 | 0.110 |
Why?
|
Weight Gain | 1 | 2023 | 2293 | 0.110 |
Why?
|
Adolescent | 6 | 2021 | 85779 | 0.110 |
Why?
|
Liver Function Tests | 1 | 2013 | 528 | 0.100 |
Why?
|
Triglycerides | 1 | 2019 | 2453 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2022 | 2073 | 0.100 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 2873 | 0.100 |
Why?
|
Pituitary-Adrenal System | 1 | 2015 | 553 | 0.100 |
Why?
|
Spleen | 1 | 2017 | 2362 | 0.100 |
Why?
|
RNA, Viral | 1 | 2020 | 2901 | 0.100 |
Why?
|
Peritonitis | 1 | 2013 | 365 | 0.100 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2015 | 703 | 0.090 |
Why?
|
Adipose Tissue | 1 | 2022 | 3280 | 0.090 |
Why?
|
Heart Failure | 3 | 2022 | 10895 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 3511 | 0.090 |
Why?
|
Hypothyroidism | 1 | 2015 | 658 | 0.090 |
Why?
|
Body Composition | 1 | 2019 | 2402 | 0.090 |
Why?
|
Cohort Studies | 3 | 2021 | 40559 | 0.090 |
Why?
|
Biopsy | 1 | 2021 | 6755 | 0.080 |
Why?
|
Viral Load | 1 | 2018 | 3300 | 0.080 |
Why?
|
Anti-Retroviral Agents | 1 | 2018 | 1714 | 0.080 |
Why?
|
Prednisone | 1 | 2013 | 1574 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2013 | 1851 | 0.080 |
Why?
|
Plaque, Atherosclerotic | 1 | 2020 | 1519 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2214 | 0.080 |
Why?
|
Cardiomyopathies | 1 | 2019 | 1912 | 0.080 |
Why?
|
Myocardium | 1 | 2019 | 4772 | 0.070 |
Why?
|
Liver Neoplasms | 2 | 2020 | 4253 | 0.070 |
Why?
|
Pituitary Neoplasms | 1 | 2015 | 1345 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2019 | 21748 | 0.070 |
Why?
|
Prevalence | 2 | 2020 | 15221 | 0.070 |
Why?
|
Aged | 6 | 2021 | 163288 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13286 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9955 | 0.060 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2013 | 1004 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2020 | 4255 | 0.060 |
Why?
|
Liver Diseases | 1 | 2012 | 1253 | 0.060 |
Why?
|
Adenoma | 1 | 2015 | 2174 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2013 | 1790 | 0.060 |
Why?
|
Infant, Newborn | 1 | 2023 | 25628 | 0.060 |
Why?
|
Databases, Factual | 1 | 2018 | 7730 | 0.060 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2535 | 0.050 |
Why?
|
Infant | 1 | 2023 | 35134 | 0.050 |
Why?
|
Osteopontin | 1 | 2022 | 294 | 0.050 |
Why?
|
Risk Factors | 4 | 2020 | 72296 | 0.050 |
Why?
|
Ultrasonography | 1 | 2013 | 5984 | 0.050 |
Why?
|
Inflammation | 1 | 2020 | 10637 | 0.040 |
Why?
|
Thyroxine | 1 | 2023 | 667 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29060 | 0.040 |
Why?
|
Child | 3 | 2023 | 77709 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2022 | 670 | 0.040 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 3666 | 0.040 |
Why?
|
United States | 3 | 2020 | 69872 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2019 | 63107 | 0.030 |
Why?
|
Fibrosis | 1 | 2022 | 2029 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2022 | 1320 | 0.030 |
Why?
|
Prospective Studies | 4 | 2023 | 53290 | 0.030 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2021 | 1206 | 0.030 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2012 | 32 | 0.030 |
Why?
|
Adenoma, Liver Cell | 1 | 2012 | 33 | 0.030 |
Why?
|
Reference Values | 1 | 2018 | 4982 | 0.020 |
Why?
|
Stroke Volume | 1 | 2022 | 5006 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25039 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2019 | 3759 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8319 | 0.020 |
Why?
|
Hemangioma | 1 | 2012 | 738 | 0.020 |
Why?
|
Cysts | 1 | 2012 | 678 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2012 | 1205 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39052 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15535 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 77460 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 35425 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 13882 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2012 | 57776 | 0.000 |
Why?
|